Free Trial

Aemetis (AMTX) Expected to Announce Earnings on Thursday

Aemetis logo with Oils/Energy background
Remove Ads

Aemetis (NASDAQ:AMTX - Get Free Report) is anticipated to release its earnings data before the market opens on Thursday, March 6th. Analysts expect Aemetis to post earnings of ($0.46) per share and revenue of $80.59 million for the quarter.

Aemetis Price Performance

Shares of NASDAQ:AMTX traded up $0.03 on Friday, reaching $1.75. 255,366 shares of the company traded hands, compared to its average volume of 846,281. The company's 50 day moving average is $2.33 and its 200-day moving average is $2.72. Aemetis has a fifty-two week low of $1.60 and a fifty-two week high of $7.03. The stock has a market capitalization of $89.26 million, a PE ratio of -0.77 and a beta of 1.48.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on AMTX. StockNews.com upgraded shares of Aemetis to a "sell" rating in a research report on Wednesday, February 5th. HC Wainwright restated a "buy" rating and issued a $28.00 price objective on shares of Aemetis in a research report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $14.56.

View Our Latest Stock Report on AMTX

About Aemetis

(Get Free Report)

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

Recommended Stories

Earnings History for Aemetis (NASDAQ:AMTX)

Should You Invest $1,000 in Aemetis Right Now?

Before you consider Aemetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aemetis wasn't on the list.

While Aemetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads